Rana joined Brandon Capital Partners in 2021.
Prior to this, Rana was one of the founding employees of Argenta, a global research and manufacturing veterinary pharmaceutical company. She departed as the Head of Innovation and was responsible for the company’s IP portfolio, from inception through development and securing global licenses for novel new technology and products. She has international experience in pharmaceutical development, manufacturing and IP management and commercialisation.
Previously, Rana held roles in the fields of pharmaceutical engineering, design and build and pioneered Argenta’s project management capability. Her early international roles were focused on setting up and integrating new manufacturing operations in the US and UK and cultivating new business relationships. Rana lived and worked in the US for several years after relocating in 2016. The pull of family and her home in New Zealand had her return at the end of 2020.
Rana has a strong scientific and engineering base with technical understanding and experience in new product development and the subsequent marketing and licensing of the resultant IP. She has a deep passion for customer experience and her skills are focused on ensuring the company’s brand is held in the highest regard throughout any business relationship.
Rana has a Bachelor of Engineering – Chemical and Materials (Honours) and a Masters of Engineering – Chemical Engineering (Honours), both from the University of Auckland.